Additional Information

Description

GenVisc 850 is a sterile, non-pyrogenic, viscoelastic solution containing purified, high molecular weight sodium hyaluronate. This injectable product is designed to be used in the management of osteoarthritis (OA) pain, particularly in patients who have not responded adequately to conservative non-pharmacologic therapy and simple analgesics like acetaminophen.

GenVisc 850 is administered as an intra-articular injection into the knee joint, and its formulation aims to restore the normal viscoelastic properties of synovial fluid. The injection serves as a non-surgical alternative for pain management in patients with knee osteoarthritis, particularly those in whom other therapies have been ineffective.

The use of GenVisc 850 in osteoarthritis treatment is backed by clinical evidence demonstrating its effectiveness in alleviating pain, improving joint function, and enhancing mobility. By reducing the friction within the joint, it helps to decrease inflammation and provide symptomatic relief in patients with degenerative changes in the knee.